Filing Details

Accession Number:
0001209191-17-046330
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-26 16:52:20
Reporting Period:
2017-07-25
Filing Date:
2017-07-26
Accepted Time:
2017-07-26 16:52:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1478069 Contrafect Corp CFRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615039 Michael Messinger 660 West 232Nd Street
Bronx NY 10463
Svp Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2017-07-25 800 $1.24 14,091 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0001 Per Share Warrants (Right to Buy) Acquisiton 2017-07-25 400 $0.01 400 $1.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
400 2017-07-25 2022-07-25 No 4 P Direct